Skip Navigation


Nucleic Acids Research Advance Access originally published online on June 21, 2007
Nucleic Acids Research 2007 35(13):4535-4541; doi:10.1093/nar/gkm480
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (386K) Freely available
Right arrow Screen PDF (194K) Freely available
Right arrow Supplementary Material
Right arrowOA All Versions of this Article:
35/13/4535    most recent
gkm480v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Yu, Z.
Right arrow Articles by Shen, S.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, Z.
Right arrow Articles by Shen, S.-H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2007, Vol. 35, No. 13 4535-4541
© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Genomics

Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers

Zhenbao Yu1,{dagger}, Zhen Li1,2,{dagger}, Normand Jolicoeur1,{dagger}, Linhua Zhang1, Yves Fortin1, Edwin Wang1, Meiqun Wu1 and Shi-Hsiang Shen1,2,*

1Health Sector, Biotechnology Research Institute, National Research Council of Canada, 6100 Royalmount Avenue, Montréal, Québec, Canada, H4P 2R2 and 2Department of Medicine, McGill University, Montréal, Québec, Canada, H3G 1A4

*To whom correspondence should be addressed. Tel: +514 496 6318; Fax: +514 496 6319; Email: shi.shen{at}cnrc-nrc.gc.ca Correspondence may also be addressed to Zhenbao Yu. Tel: +514 496 6377; Fax: +514 496 6319; Email: zhenbao.yu{at}nrc.ca

Received October 3, 2006. Revised May 11, 2007. Accepted May 31, 2007.

MicroRNAs (miRNAs) are a class of noncoding small RNAs that regulate gene expression by base pairing with target mRNAs at the 3'-terminal untranslated regions (3'-UTRs), leading to mRNA cleavage or translational repression. Single-nucleotide polymorphisms (SNPs) located at miRNA-binding sites (miRNA-binding SNPs) are likely to affect the expression of the miRNA target and may contribute to the susceptibility of humans to common diseases. We herein performed a genome-wide analysis of SNPs located in the miRNA-binding sites of the 3'-UTR of various human genes. We found that miRNA-binding SNPs are negatively selected in respect to SNP distribution between the miRNA-binding ‘seed’ sequence and the entire 3'-UTR sequence. Furthermore, we comprehensively defined the expression of each miRNA-binding SNP in cancers versus normal tissues through mining EST databases. Interestingly, we found that some miRNA-binding SNPs exhibit significant different allele frequencies between the human cancer EST libraries and the dbSNP database. More importantly, using human cancer specimens against the dbSNP database for case-control association studies, we found that twelve miRNA-binding SNPs indeed display an aberrant allele frequency in human cancers. Hence, SNPs located in miRNA-binding sites affect miRNA target expression and function, and are potentially associated with cancers.


{dagger}The authors wish it to be known that, in their opinion, the first three authors should be regarded as joint First Authors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
GutHome page
T Paranjape, F J Slack, and J B Weidhaas
MicroRNAs: tools for cancer diagnostics
Gut, November 1, 2009; 58(11): 1546 - 1554.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Song, H. Zheng, B. Liu, S. Wei, H. Dai, L. Zhang, G. A. Calin, X. Hao, Q. Wei, W. Zhang, et al.
An miR-502-Binding Site Single-Nucleotide Polymorphism in the 3'-Untranslated Region of the SET8 Gene Is Associated with Early Age of Breast Cancer Onset
Clin. Cancer Res., October 1, 2009; 15(19): 6292 - 6300.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Saetrom, J. Biesinger, S. M. Li, D. Smith, L. F. Thomas, K. Majzoub, G. E. Rivas, J. Alluin, J. J. Rossi, T. G. Krontiris, et al.
A Risk Variant in an miR-125b Binding Site in BMPR1B Is Associated with Breast Cancer Pathogenesis
Cancer Res., September 15, 2009; 69(18): 7459 - 7465.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
G. Sun, J. Yan, K. Noltner, J. Feng, H. Li, D. A. Sarkis, S. S. Sommer, and J. J. Rossi
SNPs in human miRNA genes affect biogenesis and function
RNA, September 1, 2009; 15(9): 1640 - 1651.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
M. Kato, L. Arce, and R. Natarajan
MicroRNAs and Their Role in Progressive Kidney Diseases
Clin. J. Am. Soc. Nephrol., July 1, 2009; 4(7): 1255 - 1266.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
S. Savas and G. Liu
Studying Genetic Variations in Cancer Prognosis (and Risk): A Primer for Clinicians
Oncologist, July 1, 2009; 14(7): 657 - 666.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Fabbri, N. Valeri, and G. A. Calin
MicroRNAs and genomic variations: from Proteus tricks to Prometheus gift
Carcinogenesis, June 1, 2009; 30(6): 912 - 917.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Tchatchou, A. Jung, K. Hemminki, C. Sutter, B. Wappenschmidt, P. Bugert, B. H.F. Weber, D. Niederacher, N. Arnold, R. Varon-Mateeva, et al.
A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women
Carcinogenesis, January 1, 2009; 30(1): 59 - 64.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. J. Chin, E. Ratner, S. Leng, R. Zhai, S. Nallur, I. Babar, R.-U. Muller, E. Straka, L. Su, E. A. Burki, et al.
A SNP in a let-7 microRNA Complementary Site in the KRAS 3' Untranslated Region Increases Non-Small Cell Lung Cancer Risk
Cancer Res., October 15, 2008; 68(20): 8535 - 8540.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Kapeller, L. A. Houghton, H. Monnikes, J. Walstab, D. Moller, H. Bonisch, B. Burwinkel, F. Autschbach, B. Funke, F. Lasitschka, et al.
First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome
Hum. Mol. Genet., October 1, 2008; 17(19): 2967 - 2977.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Wu, N. Jolicoeur, Z. Li, L. Zhang, Y. Fortin, D. L'Abbe, Z. Yu, and S.-H. Shen
Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs
Carcinogenesis, September 1, 2008; 29(9): 1710 - 1716.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Chen, F. Song, G. A. Calin, Q. Wei, X. Hao, and W. Zhang
Polymorphisms in microRNA targets: a gold mine for molecular epidemiology
Carcinogenesis, July 1, 2008; 29(7): 1306 - 1311.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Landi, F. Gemignani, A. Naccarati, B. Pardini, P. Vodicka, L. Vodickova, J. Novotny, A. Forsti, K. Hemminki, F. Canzian, et al.
Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer
Carcinogenesis, March 1, 2008; 29(3): 579 - 584.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.